Compare EHang Holdings Ltd - ADR (EH) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Zimmer Biomet Holdings Inc — how do they compare? EHang Holdings Ltd - ADR trades at $5.85 (market cap $437.63M), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 42.4× EHang Holdings Ltd - ADR's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | ZBH | |
|---|---|---|
Market Cap | $437.63M | $18.55B |
Sector | Industrials | Health |
52-Week High | $19.44 | $107.71 |
52-Week Low | $4.90 | $79.58 |
Enterprise Value | $376.84M | $25.61B |
Dividend Yield | — | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
